Experience in many types of respiratory clinical trials makes Java CR an ideal CRO

Respiratory disorders due to environmental as well as genetic factors are on the rise globally. As health bodies around the world search for innovative and effective treatments for respiratory function the demand for respiratory clinical trials increases.

Java Clinical Research has established strong working relationships with many world renowned experts in the areas of respiratory medicine and clinical trials. As well as having access to experts in the field of respiratory medicine Java CR also has a comprehensive experience in carrying out studies over a broad range of respiratory indications.

Through many years of collaborative work and CRO service delivery Java CR has particular experience with Cystic Fibrosis (CF) studies. The company has immediate access to large patient populations with which to conduct appropriate clinical trials because Ireland has one of the highest rates of CF in the world.

Along with this specialist interest in CF Java Clinical Research has comprehensive experience in other respiratory clinical trial areas such as Chronic Pulmonary Obstructive Disease. While in developed countries rates of COPD are increasing at lower rates due to greater awareness of the negative effects of smoking and airborne pollutants in the developed world rates are increasing at a much higher rate as tobacco products become more affordable and expanding industry creates more and more pollutants. Clinical trials for treatments of COPD will continue to be a high priority for the foreseeable future as developing countries look to developed nations for therapies to treat these conditions.

Java CR also has a great deal of experience carrying out studies in indicators such as asthma, acute and chronic sinusitis, both seasonal and perennial allergic rhinitis as well as numerous other lung and respiratory system diseases.

Java CR works with many experts in respiratory illness who are dedicated to state-of-the-art translational research. This is where hypotheses of respiratory disease mechanisms and disease causes derived from clinical evaluation can be verified in specialist genetic and proteomic research laboratories.